BOOK
Congenital Heart Disease in Adults E-Book
Joseph K. Perloff | John S. Child | Jamil Aboulhosn
(2008)
Additional Information
Book Details
Abstract
Dr. Perloff, the founding father of the field of adult congenital heart disease, presents a decade’s worth of research and clinical data in the completely redefined 3rd edition to bring you the most current information. With advances in diagnosis and treatment in children, more and more of those with CHD survive well into adulthood. Expert contributors in various fields offer a multi-disciplinary, multi-system approach to treatment so you get comprehensive coverage on all aspects of the subspecialty, including basic unoperated malformations, medical and surgical perspectives, postoperative residue, and sequelae. As someone who treats these patients, you need to be ready to provide the continual care they require.
- Conveys a multidisciplinary, multi-system approach to the lifelong care of adult CHD patients to put treatment in a broader context.
- Presents information in a consistent, logical style so the information you need is easy to find and apply.
- Supplements the text with 600 clear conceptual illustrations to clarify difficult concepts.
- Features completely rewritten chapters to include the latest developments in the field—such as major advances in surgical and interventional techniques—and the various needs of patients with adult CHD.
- Incorporates recently published trials such as those involving cyanotic CHD and atherogenesis, coronary microcirculation, and pathogenesis of thrombocytopenia to supplement the chapter on cyanotic CHD.
- Emphasizes advances in imaging in a new section—edited by an expert—that covers echocardiography as well as specialized imaging techniques.
- Illustrates the full range of advances in the field with 600 images that reflect the latest progress.
- Includes new chapters—Global Scope of ACHD; Cardiac Transplantation; Electrophysiologic Abnormalities in Unoperated Patients and Residue and Sequelae After Cardiac Surgery—to provide you with the latest information on the growth of the subspecialty and its effect on treatment.
- Presents revisions by a new authorship of experts in infectious disease, genetics and epidemiology, sports medicine, neurology, cardiac surgery, cardiac anesthesiology, and more.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Congenital Heart Disease in Adults | iii | ||
| Copyright Page | iv | ||
| Table of Contents | xi | ||
| Contributors | v | ||
| Preface | vii | ||
| Acknowledgments | ix | ||
| SECTION I: BACKGROUND AND FACILITIES | 1 | ||
| CHAPTER 1. Historical Perspective | 3 | ||
| CHAPTER 2. National and International Scope | 14 | ||
| CHAPTER 3. Specialized Facilities for Adults with Congenital Heart Disease | 18 | ||
| FACULTY AND PATIENT POPULATION | 18 | ||
| CARDIAC AND NONCARDIAC CONSULTANTS | 19 | ||
| OUTPATIENT SERVICES | 19 | ||
| INPATIENT SERVICES | 20 | ||
| NONINVASIVE AND IMAGING LABORATORIES | 20 | ||
| DIAGNOSTIC AND INTERVENTIONAL CATHETERIZATION LABORATORIES | 20 | ||
| TRAINING, EDUCATION, AND RESEARCH | 20 | ||
| FUNCTIONAL CLASSIFICATIONS | 21 | ||
| SECTION II: SURVIVAL PATTERNS | 23 | ||
| CHAPTER 4. Survival Patterns Without Cardiac Surgery or Interventional Catheterization: A Narrowing Base | 25 | ||
| BICUSPID AORTIC VALVE | 25 | ||
| UNICUSPID AORTIC VALVE | 27 | ||
| QUADRICUSPID AORTIC VALVE | 27 | ||
| COARCTATION OF THE AORTA | 28 | ||
| FIXED SUBAORTIC STENOSIS | 29 | ||
| SUPRAVALVE AORTIC STENOSIS | 31 | ||
| EBSTEIN’S ANOMALY OF THE TRICUSPID VALVE | 31 | ||
| UHL’S ANOMALY | 32 | ||
| CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES (VENTRICULAR INVERSION) | 32 | ||
| CONGENITAL MITRAL REGURGITATION | 33 | ||
| PULMONARY VALVE STENOSIS | 33 | ||
| PULMONARY VALVE REGURGITATION | 35 | ||
| PULMONARY ARTERY STENOSIS | 35 | ||
| OSTIUM SECUNDUM ATRIAL SEPTAL DEFECT | 35 | ||
| IDIOPATHIC PULMONARY HYPERTENSION | 37 | ||
| LUTEMBACHER SYNDROME | 37 | ||
| SINUS VENOSUS ATRIAL SEPTAL DEFECTS | 38 | ||
| PARTIAL ANOMALOUS PULMONARY VENOUS CONNECTION | 39 | ||
| TOTAL ANOMALOUS PULMONARY VENOUS CONNECTION | 40 | ||
| COMMON ATRIUM | 40 | ||
| ATRIOVENTRICULAR SEPTAL DEFECT | 40 | ||
| PATENT DUCTUS ARTERIOSUS | 41 | ||
| VENTRICULAR SEPTAL DEFECT | 42 | ||
| DEFECTS IN THE INFUNDIBULAR SEPTUM | 43 | ||
| SINUS OF VALSALVA ANEURYSM | 44 | ||
| TRUNCUS ARTERIOSUS | 44 | ||
| COMPLETE TRANSPOSITION OF THE GREAT ARTERIES | 45 | ||
| DOUBLE-OUTLET VENTRICLE | 45 | ||
| TAUSSIG-BING ANOMALY | 47 | ||
| TETRALOGY OF FALLOT | 47 | ||
| TETRALOGY OF FALLOT WITH ABSENT PULMONARY VALVE | 48 | ||
| SITUS INVERSUS WITH DEXTROCARDIA | 48 | ||
| SITUS SOLITUS WITH DEXTROCARDIA | 48 | ||
| VISCERAL HETEROTAXY WITH LEFT ISOMERISM (BILATERAL LEFT-SIDEDNESS) | 49 | ||
| ISOLATED CONGENITAL COMPLETE HEART BLOCK | 49 | ||
| VENA CAVAL TO LEFT ATRIAL COMMUNICATIONS | 50 | ||
| CORONARY ARTERIAL FISTULA | 51 | ||
| ANOMALOUS ORIGIN OF THE LEFT CORONARY ARTERY FROM THE PULMONARY TRUNK | 51 | ||
| PULMONARY ARTERIOVENOUS FISTULAE | 53 | ||
| UNIVENTRICULAR HEART | 54 | ||
| TRICUSPID ATRESIA | 55 | ||
| CONGENITAL OBSTRUCTION TO LEFT ATRIAL FLOW | 56 | ||
| VASCULAR RINGS | 56 | ||
| CONGENITAL COMPLETE ABSENCE OF THE PERICARDIUM | 57 | ||
| CHAPTER 5. Survival Patterns After Cardiac Surgery or Interventional Catheterization: A Broadening Base | 68 | ||
| CONGENITALLY MALFORMED CARDIAC VALVES | 68 | ||
| INTRAATRIAL SURGERY | 72 | ||
| INTRAATRIAL SURGERY FOR COMPLEX CYANOTIC CONGENITAL HEART DISEASE | 76 | ||
| CENTRAL ARTERIAL SURGERY | 89 | ||
| SECTION III: MEDICAL CONSIDERATIONS | 103 | ||
| CHAPTER 6. Echocardiography in Anatomic Imaging and Hemodynamic Evaluation of Adults with Congenital Heart Disease | 105 | ||
| COMPREHENSIVE ANATOMIC AND HEMODYNAMIC ECHOCARDIOGRAPHY | 105 | ||
| DIGITAL ECHOCARDIOGRAPHY | 107 | ||
| VENTRICULAR FUNCTION | 107 | ||
| NEW AND EVOLVING ECHO-DOPPLER TECHNIQUES | 108 | ||
| SEGMENTAL APPROACH TO THE DIAGNOSIS OF CONGENITAL HEART DISEASE | 110 | ||
| SIMPLE SHUNT LESIONS | 112 | ||
| SPECIFIC SIMPLE SHUNT LESIONS | 113 | ||
| SIMPLE OBSTRUCTIVE AND REGURGITANT LESIONS | 123 | ||
| ISOLATED LEFT VENTRICULAR NONCOMPACTION | 129 | ||
| COMPLEX MALFORMATIONS | 130 | ||
| CHAPTER 7. Cardiac Magnetic Resonance Imaging and Computed Tomography in the Assessment of Adult Congenital Heart Disease | 151 | ||
| BACKGROUND | 151 | ||
| CLINICAL EVALUATION OF ADULT CONGENITAL HEART DISEASE | 153 | ||
| PHYSIOLOGIC ASSESSMENT OF FUNCTION AND FLOW | 162 | ||
| FUTURE OF MAGNETIC RESONANCE IMAGING AND COMPUTED TOMOGRAPHY | 165 | ||
| CHAPTER 8. Infective Endocarditis and Congenital Heart Disease | 168 | ||
| HISTORICAL PERSPECTIVE | 168 | ||
| EPIDEMIOLOGY | 169 | ||
| PATHOGENESIS | 169 | ||
| CONGENITAL HEART DISEASE AND INFECTIVE ENDOCARDITIS | 170 | ||
| DIAGNOSIS | 175 | ||
| COMPLICATIONS | 179 | ||
| TREATMENT OF ENDOCARDITIS | 180 | ||
| PREVENTION AND PROPHYLAXIS | 185 | ||
| PATIENT AND PHYSICIAN EDUCATION | 189 | ||
| CHAPTER 9. Management of Pregnancy and Contraception in Congenital Heart Disease | 194 | ||
| HISTORICAL PERSPECTIVE | 194 | ||
| CARDIAC DISEASE AND PREGNANCY—AN OVERVIEW | 195 | ||
| CARDIOVASCULAR PHYSIOLOGY DURING NORMAL PREGNANCY, LABOR, AND DELIVERY | 195 | ||
| CARDIAC SIGNS AND SYMPTOMS DURING PREGNANCY | 197 | ||
| ECHOCARDIOGRAPHY | 197 | ||
| PRINCIPLES OF GENERAL MANAGEMENT | 197 | ||
| PRECONCEPTION EVALUATION AND COUNSELING | 198 | ||
| HIGH-RISK CARDIAC DISEASE | 199 | ||
| LOW-RISK HEART DISEASE | 200 | ||
| DRUGS DURING PREGNANCY | 200 | ||
| CARDIAC SURGERY DURING PREGNANCY | 201 | ||
| LABOR AND DELIVERY | 201 | ||
| SPECIFIC CONGENITAL CARDIOVASCULAR MALFORMATIONS | 203 | ||
| MARFAN SYNDROME | 211 | ||
| PROSTHETIC HEART VALVES AND ANTICOAGULATION | 212 | ||
| ORAL VITAMIN K ANTAGONISTS | 214 | ||
| HEPARINS | 215 | ||
| RECOMMENDATIONS FOR ANTICOAGULATION OF MECHANICAL HEART VALVES DURING PREGNANCY | 216 | ||
| BENEFITS AND RISKS OF CONTRACEPTION | 217 | ||
| GYNECOLOGIC ENDOCRINOLOGY | 218 | ||
| CHAPTER 10. Genetics, Epidemiology, and Counseling | 221 | ||
| EPIDEMIOLOGY | 221 | ||
| ETIOLOGY | 223 | ||
| CLINICAL PRACTICE | 238 | ||
| CONCLUSION | 242 | ||
| CHAPTER 11. Exercise and Athletics in Adults with Congenital Heart Disease | 248 | ||
| COMPETITIVE AND RECREATIONAL ATHLETICS | 248 | ||
| TYPES OF EXERCISE | 249 | ||
| EFFECTS OF EXERCISE ON SPECIFIC TYPES OF CONGENITAL HEART DISEASE | 250 | ||
| CHAPTER 12. Cyanotic Congenital Heart Disease: A Multisystem Disorder | 265 | ||
| HEMATOLOGIC ISSUES | 265 | ||
| OTHER THERAPEUTIC RECOMMENDATIONS | 269 | ||
| OTHER HEMATOLOGIC DISORDERS | 271 | ||
| SYSTEMIC VASCULAR BED | 274 | ||
| CORONARY CIRCULATION | 274 | ||
| RENAL INVOLVEMENT | 276 | ||
| DIGITS AND LONG BONES | 277 | ||
| LUNGS—RESPIRATION, OXYGEN CONSUMPTION, AND VENTILATION | 280 | ||
| CHAPTER 13. Psychiatric and Psychosocial Disorders in Congenital Heart Disease | 290 | ||
| MECHANISMS OF CENTRAL NERVOUS SYSTEM INJURY IN CONGENITAL HEART DISEASE | 290 | ||
| PREOPERATIVE AND INTRINSIC FACTORS | 290 | ||
| INTRAOPERATIVE RISK FACTORS | 292 | ||
| EFFECTS OF SURGICAL INTERVENTION IN INFANTS AND CHILDREN WITH CONGENITAL HEART DISEASE | 293 | ||
| IMMEDIATE POSTOPERATIVE CONCERNS | 294 | ||
| SURGICAL INTERVENTION AND COGNITIVE IMPAIRMENT | 294 | ||
| DEVELOPMENT ACROSS THE LIFE SPAN | 295 | ||
| CLINICAL PSYCHIATRIC ISSUES | 298 | ||
| PHARMACOLOGIC TREATMENT | 299 | ||
| CARDIAC TRANSPLANTATION IN CHILDREN AND ADOLESCENTS | 300 | ||
| SUMMARY | 301 | ||
| CHAPTER 14. Neurologic Disorders | 307 | ||
| INFECTIOUS DISORDERS | 307 | ||
| ISCHEMIC DISORDERS | 308 | ||
| HEMORRHAGIC DISORDERS | 315 | ||
| SYNCOPE | 316 | ||
| HYPOXIC DISORDERS | 316 | ||
| SEIZURE DISORDERS | 316 | ||
| CONGENITAL NEUROLOGIC DISORDERS | 317 | ||
| NEUROLOGIC SEQUELAE OF CARDIAC SURGERY | 317 | ||
| PERIPHERAL MODEL OF CENTRAL NERVOUS SYSTEM NEURONAL FUNCTION | 317 | ||
| SECTION IV: SURGICAL CONSIDERATIONS | 321 | ||
| CHAPTER 15. Cardiac Surgery in Adults with Congenital Heart Disease: Operation and Reoperation | 323 | ||
| SYSTEMIC-TO-PULMONARY ARTERIAL SHUNTS | 323 | ||
| POTTS OR WATERSTON SHUNTS | 323 | ||
| GLENN SHUNT | 324 | ||
| PULMONARY ARTERIAL BANDING | 324 | ||
| GENERAL MANAGEMENT | 324 | ||
| SPECIFIC CONGENITAL MALFORMATIONS | 325 | ||
| CHAPTER 16. Prosthetic Materials: Selection, Use, and Long-Term Effects | 342 | ||
| ENDOGENOUS AUTOGRAFT BIOPROSTHETIC MATERIALS | 342 | ||
| EXOGENOUS BIOPROSTHETIC MATERIALS | 343 | ||
| SYNTHETIC MATERIALS | 344 | ||
| PROSTHETIC RINGS | 346 | ||
| MECHANICAL VALVES | 346 | ||
| GUIDELINES FOR CHOOSING PROSTHETIC MATERIALS | 346 | ||
| GUIDELINES FOR ANTICOAGULATION | 347 | ||
| CHAPTER 17. Cardiac Transplantation in Patients with Congenital Heart Disease | 350 | ||
| INDICATIONS FOR HEART TRANSPLANTATION IN PATIENTS WITH CONGENITAL HEART DISEASE | 350 | ||
| SPECIAL CONSIDERATIONS FOR PATIENTS WITH CONGENITAL HEART DISEASE | 351 | ||
| OPTIMAL IMMUNOSUPPRESSION AFTER HEART TRANSPLANTATION | 354 | ||
| CONCLUSION | 355 | ||
| CHAPTER 18. Transcatheter Interventions in Adult Congenital Heart Disease | 357 | ||
| INTERVENTIONS FOR SEMILUNAR VALVE AND VENTRICULAR OUTFLOW OBSTRUCTION | 357 | ||
| PULMONARY ARTERY STENOSIS | 359 | ||
| CONDUIT AND PROSTHETIC VALVE STENOSIS | 360 | ||
| LEFT VENTRICULAR OUTFLOW AND AORTIC VALVE OBSTRUCTION | 361 | ||
| EMBOLIZATION | 363 | ||
| OCCLUSION DEVICES | 366 | ||
| TRANSCATHETER VALVE PROCEDURES | 371 | ||
| TRANSCATHETER APPLICATIONS TO THE SINGLE VENTRICLE | 374 | ||
| CHAPTER 19. Noncardiac Surgery | 380 | ||
| GENERAL CONSIDERATIONS | 380 | ||
| UNOPERATED ACYANOTIC CONGENITAL HEART DISEASE | 381 | ||
| UNOPERATED CYANOTIC CONGENITAL HEART DISEASE | 384 | ||
| SURGICALLY REPAIRED CONGENITAL HEART DISEASE | 386 | ||
| SECTION V: RESIDUA AND SEQUELAE AFTER SURGERY OR INTERVENTIONAL CATHETERIZATION | 391 | ||
| CHAPTER 20. Residua and Sequelae: A Perspective | 393 | ||
| RESIDUA | 393 | ||
| SEQUELAE | 401 | ||
| CHAPTER 21. Residua and Sequelae Involving Cardiac Valves | 407 | ||
| RESIDUA | 407 | ||
| SEQUELAE | 413 | ||
| CHAPTER 22. Electrophysiologic Abnormalities: Unoperated Occurrence and Postoperative Residua and Sequelae | 418 | ||
| PATHOPHYSIOLOGY—MECHANISMS OF CARDIAC ARRHYTHMIAS | 419 | ||
| MECHANISMS OF CARDIAC ARRHYTHMIAS | 419 | ||
| ARRHYTHMIAS IN THE SETTING OF ACUTE MYOCARDIAL ISCHEMIA | 422 | ||
| RECENT ADVANCES | 422 | ||
| MANAGEMENT | 422 | ||
| FUTURE | 425 | ||
| MALFORMATIONS INVOLVING INTRAATRIAL SURGERY | 426 | ||
| MALFORMATIONS REQUIRING INTRAVENTRICULAR SURGERY | 433 | ||
| CONGENITAL DISEASES OF CARDIAC VALVES | 440 | ||
| MYOCARDIAL DISEASES | 442 | ||
| THERAPY FOR ARRHYTHMIAS | 446 | ||
| CHAPTER 23. Myocardial Growth and the Development and Regression of Increased Ventricular Mass | 460 | ||
| NORMAL INTRAUTERINE CARDIAC GROWTH | 461 | ||
| NORMAL EXTRAUTERINE CARDIAC GROWTH | 463 | ||
| INCREASE IN VENTRICULAR MASS BEYOND THE PROCESS OF NORMAL GROWTH | 464 | ||
| ULTRASTRUCTURAL RESPONSES TO OVERLOAD | 466 | ||
| GROSS MORPHOLOGIC AND PHYSIOLOGIC RESPONSES TO OVERLOAD | 467 | ||
| REGRESSION OF VENTRICULAR MASS | 468 | ||
| OBJECTIVES OF OPERATION | 470 | ||
| CONCLUSION | 470 | ||
| INDEX | 475 |